Background: The usefulness of induced sputum in searching for causative agents of pneumonia in children has not been studied.
Methods: The study involved 101 children, aged 6 months to 15 years, treated for community-acquired pneumonia at Turku University Hospital (Turku, Finland) from January 2006 to April 2007. Nasopharyngeal aspirate samples were first collected through both nostrils. Sputum production was then induced by inhalation of 5.0% hypertonic saline for 5–10 min and a sputum sample was either aspirated or expectorated. The presence and amount of bacteria and viruses in paired nasopharyngeal aspirate and sputum specimens was analysed and compared using semiquantitative bacterial culture and quantitative PCR techniques.
Results: A good quality sputum specimen was obtained from 76 children. The possible causative agent was found in 90% of cases. Streptococcus pneumoniae (46%) and rhinovirus (29%) were the most common microbes detected. Newly discovered viruses human bocavirus and human metapneumovirus were detected in 18% and 13% of the children, respectively. One-quarter of all bacterial findings were only detected in sputum, and the amount of bacteria in the remainder of the sputum specimens compared with nasopharyngeal aspirate was higher in 14% and equal in 70%. The amount of rhinovirus in sputum was higher than in nasopharyngeal aspirate in 82%.
Conclusions: Sputum induction provides good quality sputum specimens with high microbiological yield in children with community-acquired pneumonia. Induced sputum analysis can be useful in the microbiological diagnosis of childhood community-acquired pneumonia.
Statistics from Altmetric.com
The establishment of a definite microbiological diagnosis of childhood community-acquired pneumonia (CAP) is necessary but challenging. Although most cases of childhood pneumonia can be successfully treated with empirical antibiotic therapy,1 2 identification of the aetiological agent(s) is essential if the child is critically ill or if the first-line antibiotic treatment fails to be effective. In addition, the increasing incidence of bacterial antibiotic resistance accentuates the importance of accurate microbiological diagnosis.3 4
In adults, sputum Gram stain and culture are often performed to define the microbiological diagnosis of pneumonia.5 6 In children, sputum analysis has not been considered feasible because young children cannot produce adequate sputum samples and, in contrast to adults, the nasopharyngeal colonisation of Streptococcus pneumoniae (19–38%), Haemophilus influenzae (13–25%), Moraxella catarrhalis (22–39%) and Staphylococcus aureus (16–36%) is common in children.7–12 Previous studies in children have reported the usefulness of sputum induction in the detection of microbes normally not found in the nasopharynx such as Mycobacterium tuberculosis and Pneumocystis jirovecii.13 14
A study was performed to investigate the virological and bacteriological yield from induced sputum specimens from children with CAP and to examine whether analysis of paired nasopharyngeal aspirate and induced sputum specimens could be useful in the microbiological diagnosis of CAP in children.
Study design and patients
This study was conducted from January 2006 to April 2007 in the Paediatric Infectious Disease Ward of Turku University Hospital (Turku, Finland). Children aged 6 months to 15 years with radiologically verified CAP were eligible for the study. Pneumonia was defined as the presence of pneumonic infiltrates (alveolar or interstitial) on the chest radiograph with a simultaneous finding of signs and/or symptoms of acute infection. The clinical and laboratory data were collected through a systematic review of medical records and chest radiographs were reviewed by a paediatric radiologist according to a systematic formula.15 The findings were classified as alveolar and/or interstitial infiltrates, hyperaeration, hilar enlargement, atelectasis and pleural fluid. Perihilar peribronchial infiltrates were not interpreted as pneumonic infiltrates. Study children were evaluated and treated according to local guidelines by the duty paediatrician. Intravenous benzylpenicillin (penicillin G) was recommended as the first-line antibiotic therapy for hospitalised children with pneumonia in the study hospital during the study period. Immunisation against S pneumoniae and influenza A and B in our society was not generally recommended during the study period.
A nasopharyngeal sample was aspirated with a disposable catheter connected to a mucus extractor prior to sputum induction. Nasopharyngeal aspirate was taken from both nostrils by inserting the catheter into the back wall of the nasopharynx and drawing back while applying suction with an electronic suction device to obtain a nasopharyngeal sample and to clean the nasopharynx of nasopharyngeal mucus.
Children were pretreated with inhaled salbutamol (0.15 mg/kg, maximum dosage 5 mg) delivered by a nebuliser device to prevent bronchoconstriction. Sputum production was induced by inhalation of 5.0% hypertonic saline solution for 5–10 min.16 Hypertonic saline was delivered by a nebuliser device (Spira Moduli, Spira Oy, Hämeenlinna, Finland) attached to oxygen. A sputum sample was obtained by aspirating the nasopharynx through the nostrils with a disposable mucus extractor or by expectoration if the child was old enough to produce an adequate sputum sample. Specimens for microbiological studies were immediately prepared by dipping one sterile Coban swab and three sterile cotton swabs into each sputum and nasopharyngeal aspirate sample. The Coban swab was placed in a Coban Amies gel agar transport system with charcoal (Coban Diagnostics, Murrieta, California, USA) for bacterial culture; one cotton swab was applied over a microscope glass slide for bacterial Gram staining, two cotton swabs were placed in sterile tubes for viral antigen detection and for viral PCR analyses, and the rest of the samples were used for M pneumoniae and S pneumoniae PCR. Specimens were stored at +4°C until analysed on the following working day. All microbiological studies were performed on both sputum and nasopharyngeal aspirate specimens.
Gram staining and bacterial culture were performed on purulent portions of nasopharyngeal aspirate and sputum specimens using standard methods. The quality of the sputum specimen was assessed by evaluating the Gram stain by light microscopy under low power (10×lens objective). Sputum samples were considered of good quality if they had <25 squamous epithelial cells and >25 leucocytes per low-powered field.17 Good quality specimens were further analysed and a finding of >10 bacteria per high-powered field (100×lens objective) was reported. Sputum and nasopharyngeal specimens were cultured on chocolate and blood agar plates and the quantity of bacteria in culture was semiquantitatively defined as low (+), moderate (++) or high (+++). The following organisms were considered potential pathogens: S pneumoniae, H influenzae, M catarrhalis, S aureus, beta-haemolytic streptococci and enterococci and Enterobacteriaceae (reported only in the absence of normal respiratory flora and in cases of at least a moderate amount of bacterial growth). Bacterial blood cultures were performed using Bactec 2400 system (Becton Dickinson, Franklin Lakes, New Jersey, USA) with paediatric bottles.
For bacterial PCR studies, DNA was extracted using the High Pure PCR Template Preparation Kit (Roche Diagnostics, Mannheim, Germany) in accordance with the manufacturer’s protocol for bacteria. Before DNA extraction, purulent samples were homogenised by incubation with 0.1% dithiothreitol in equal amounts of the sample volume. Detection of M pneumoniae DNA by PCR was performed as previously described with slight modifications.18 Quantitative S pneumoniae PCR on S pneumoniae culture positive samples was carried out as previously described.19 The standard curve for S pneumoniae quantification was done using genomic DNA from S pneumoniae ATCC 6314D (American Type Culture Collection, Manassas, Virginia, USA) in tenfold dilutions ranging from 0.4 pg to 40 000 pg pneumococcal DNA per reaction.
The IgM enzyme immunoassay test for M pneumoniae in serum samples was done at the discretion of the duty paediatrician using standard methods.18
Nasopharyngeal and sputum specimens were eluted from the swabs by vortexing with 1 ml phosphate buffered saline. Nucleic acids were extracted from 550 μl aliquots of the specimens using the NucliSens easyMag automated nucleic acid extractor (BioMèrieux, Boxtel, The Netherlands) with the elution volume set to 55 μl. Quantitative RT-PCR was used to detect enteroviruses, rhinovirus and respiratory syncytial virus (RSV) as described previously.20 Human metapneumovirus (hMPV) was detected by quantitative PCR using the Amplitect Quantification Kit for Metapneumovirus Genomes, targeting the nucleoprotein gene of hMPV and Ambigen qPCR Mastermix (AME Biosciences, Toroed, Norway) as recommended by the manufacturer. Qualitative PCR targeting the polymerase gene of hMPV was performed as previously described.21 Quantitative human bocavirus (HBoV) PCR was done as described previously.22 Viral antigens for influenza A and B viruses, RSV, parainfluenza virus types 1, 2 and 3 and adenovirus were detected by time-resolved fluoroimmunoassay.23
For continuous data, comparison was performed with the Kruskal-Wallis test and, for categorical data, comparison was performed using the χ2 test or Fisher exact test. The significance level was p<0.05. Simple kappa (κ) coefficient was calculated to asses the agreement between the induced sputum and nasopharyngeal samples. The Wilcoxon signed-rank test was used to compare the S pneumoniae and rhinovirus densities in paired nasopharyngeal aspirate and sputum specimens.
A total of 133 children with radiologically-verified CAP were eligible for the study (fig 1). Sputum induction was performed on 101 (76%) of these children. The final study population consisted of 76 children from whom a good quality sputum sample was obtained. Of the good quality sputum specimens, 79% had <10 squamous epithelial cells and >25 leucocytes per low-powered field, and 21% had 10–25 squamous epithelial cells and >25 leucocytes per low-powered field. The majority of the study children had a bacterial type of pneumonia as 88% of the children had alveolar infiltration on the chest radiograph, 71% had a serum C-reactive protein (CRP) level ⩾60 mg/l and 58% had a white blood cell (WBC) count ⩾15.0×109/l on admission (table 1). Sputum induction was performed before administration of intravenous or oral antibiotic treatment in 49% of the children. The sputum sample was obtained by expectoration in 7 children (9%) and by aspirating through the nostrils in 69 children (91%). No serious adverse events were recorded during the sputum induction, but the children found hypertonic saline inhalation and repeated nasopharyngeal aspirations unpleasant.
Bacteria and viruses in induced sputum samples
A possible microbial aetiology determined by bacterial culture, M pneumoniae PCR and viral antigen detection and PCR assays was identified in 68 (90%) of the 76 children with a good quality sputum sample (table 2). Evidence of bacterial infection was detected in 79% and evidence of viral infection in 55% of the children. A single bacterial infection was found in 34% and a single viral infection in 11% of the children. Mixed infections were frequent, occurring in 54% of the study children. Two or more bacteria were found in 37%; two or more viruses in 15%; and mixed viral-bacterial infections in 45% of the children.
S pneumoniae was the most frequently isolated bacterium, detected in almost one-half of the study children, followed by M catarrhalis, H influenzae and S aureus (table 2). Compared with the culture, the sensitivities and specificities of Gram stain for the detection of S pneumoniae, M catarrhalis and H influenzae in induced sputum samples were 74% and 73%, 62% and 82%, and 46% and 83%, respectively. Evidence of M pneumoniae infection was detected in induced sputum samples by PCR in 3% of the study children and by IgM serology in 7 (19%) of the 36 children tested. Altogether, evidence of M pneumoniae infection was identified in 8 (11%) children. S pneumoniae was the only bacterium detected in 22%, H influenzae in 12% and M catarrhalis in 5% of the children. Previously given antibiotic treatment had a significant influence on the detection rate of S pneumoniae and H influenzae in sputum samples (table 2).
Rhinovirus was the most common virus detected, identified in 29% of the children by PCR (table 2). HBoV was found in sputum by PCR in 14 (18%) children and hMPV in 10 (13%) children with pneumonia. Of the 14 children who had HBoV detected in sputum, 8 (57%) had a high load of HBoV DNA (>10 000 copies/ml) in sputum, suggesting a primary symptomatic infection.24 RSV was identified in only 4% of the children.
The most frequently detected viral-bacterial combinations, found in 15% and 13% of the children, respectively, were those of rhinovirus with S pneumoniae and rhinovirus with M catarrhalis. The most common bacterial combination was that of S pneumoniae and M catarrhalis, found in 16% of the study children.
Findings in paired sputum and nasopharyngeal aspirate samples
There was a substantial (κ = 0.61–0.80) or almost perfect (κ = 0.81–1.00) agreement between the sputum and nasopharyngeal aspirate samples in most bacterial and viral findings (table 3). The only exceptions were hMPV which had moderate agreement and S aureus which had poor agreement between the samples, as 8/9 S aureus findings were only detected in sputum. In total, 24% of the bacterial findings were only detected in sputum specimens.
Semiquantitative culture results were analysed to compare the amount of bacteria in paired sputum and nasopharyngeal aspirate samples. The amount of bacteria in sputum specimens was higher in 14% and equal in 70% of all the comparisons. The amount of bacteria in S pneumoniae culture positive samples was also quantified by quantitative pneumolysin PCR. The amount of pneumococci in sputum was higher in 45% of the cases (p = 0.891). Rhinovirus was detected in higher amounts in sputum by quantitative RT-PCR in 82% of all rhinovirus-positive cases (p = 0.020).
Clinical findings according to aetiology
Children with S pneumoniae in sputum had higher WBC counts on admission than those without S pneumoniae in sputum (mean (SD) 21.7 (8.2) vs 15.3 (8.1); p<0.001). They also had higher CRP levels on admission (mean (SD) 161 (105) vs 115 (96)), but this difference was not statistically significant. Typical findings for pneumococcal pneumonia (ie, high body temperature (⩾39.0°C), leucocytosis (WBC count ⩾15.0×109/l) and high CRP level (CRP ⩾60 mg/l) were found in 66% of the study children with S pneumoniae. Children with concomitant rhinovirus/pneumococcal infection (n = 11) had the highest mean WBC counts (24.2×109/l) and mean CRP levels (181 mg/l) on admission.
Treatment failure (fever ⩾38.0°C lasting for ⩾48 h) was recorded in 6 (8%) of the 76 children. A potential causative agent/s of pneumonia was identified in 5 children (S aureus and M pneumoniae in 1; S aureus with bocavirus and RSV in 1; H influenzae and bocavirus in 1; H influenzae and M catarrhalis in 1; and bocavirus in 1).
This study has three major findings. First, sputum induction in children with CAP provides good quality sputum specimens. Second, the bacteriological and virological yield of sputum specimens is good. Third, the quantification results of the paired sputum and nasopharyngeal aspirate specimens support the notion that the majority of the bacteria and viruses found in sputum most probably originated from the lower airways.
The Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) guidelines recommend routine use of sputum Gram stain and culture for adult patients needing admission to the intensive care unit for patients with failure of outpatient antibiotic therapy and for patients with pleural effusion.6 In children with pneumonia, routine sputum analysis has not been recommended because young children cannot produce adequate sputum samples and nasopharyngeal colonisation with bacteria causing pneumonia is common in healthy children.7–12 We aimed to overcome these obstacles by inducing sputum production with hypertonic saline inhalation and by trying to minimise nasopharyngeal contamination by cleaning the nasopharynx of the mucus before sputum collection.
Our finding that S pneumoniae was detected in half of all study children and in two-thirds of children without previous antibiotic treatment confirms the major role of S pneumoniae in the aetiology of childhood pneumonia.25–27 M catarrhalis was identified in almost one-third of the children, but 81% of these cases were mixed bacterial infections, suggesting that, in most cases, M catarrhalis may be just an innocent bystander. In two previous studies in our hospital, M catarrhalis infection was serologically detected in 4–10% of children with CAP.26 28 An unexpected finding was that S aureus was detected in good quality sputum specimens in 12% of the children. All but one of these S aureus cases were found in induced sputum only. In addition, two children with S aureus in the sputum failed to respond to first-line antibiotic therapy (penicillin G), suggesting that these findings may have had true clinical implications.
There is increasing evidence of the importance of rhinovirus in lower respiratory tract infections in children and adults.29 30 Previous studies employing sensitive PCR methods have detected rhinovirus in nasal samples in 24–45% of children with pneumonia.26 31 The corresponding detection rate by culture has been approximately 10%.28 32 In the present study, rhinovirus was clearly the most common viral finding, detected by PCR in the sputum of 29% of the children. The mere presence of rhinovirus in sputum, however, offers no direct evidence of the aetiology of pneumonia, as 82% of the children with rhinovirus had evidence of concomitant bacterial infection. An interesting finding was that mixed rhinovirus/pneumococcal infection seemed to induce a more severe inflammation response than single rhinovirus or single pneumococcal infection, which is in agreement with the recent results by Jennings et al that mixed rhinovirus/pneumococcal infection is associated with severe disease in adults.30
The role of the newly discovered viruses HBoV and hMPV in the aetiology of pneumonia is not fully established. In our study, these new viruses accounted for up to 42% of all the viral cases detected. HBoV was detected in sputum samples in 18% of the children and hMPV in 13%. This is in agreement with recent findings of Cilla and coworkers who detected HBoV and hMPV in nasopharyngeal aspirate samples in 14% and 12% of children with pneumonia, respectively.33 In accordance with previous studies, we found a high viral coinfection rate (64%) in children with HBoV.33 34 The viral coinfection rate in children with hMPV was 40%. Whether the detection of these new respiratory viruses in children with pneumonia reflects a primary infection or persistence of the virus after a previous infection cannot be determined. However, 4/10 hMPV cases and 3/14 HBoV cases were only detected in sputum specimens, which suggests that, in these cases, HBoV and hMPV most probably originated from the lower respiratory tract.
RSV was found rarely, which is explained by the fact that this study was conducted during a time when there was no RSV epidemic in the community. The winter epidemic in 2006 had just ended and the spring epidemic in 2007 had not yet started.35
We are aware of the limitations of our study. The major question is whether the sputum specimens are representative samples from the lower respiratory tract. Although only good quality sputum specimens were included in the final analysis, we cannot rule out the possibility that the sputum specimens may have been contaminated with nasopharyngeal bacteria. The diagnostic accuracy of induced sputum could not be determined using a gold standard, as lung aspirates were not collected and blood culture was positive only in one child. In addition, control specimens from children with upper respiratory tract infection were not collected because we do not consider sputum induction in these children to be ethically acceptable. Furthermore, half the children had received antibiotic treatment before sputum collection.
The strength of the present study is that the amount of bacteria and viruses in paired nasopharyngeal aspirate and sputum samples were quantified and compared. We found that one-quarter of all bacterial findings were only detected in sputum, which suggests that, in these cases, induced sputum analysis most probably identified the causative agent of pneumonia. In most cases the same bacterium or virus was detected in both nasopharyngeal aspirate and sputum. In these cases, the amount of bacteria in sputum determined by semiquantitative culture was equal to or higher in 84% of all the paired comparisons, and the amount of viruses in sputum by quantitative rhinovirus , enterovirus , RSV , HBoV and hMPV PCR was higher in 73%. It is of note that these results were obtained, even though the nasopharynx was carefully cleaned of mucus before sputum induction and collection. However, it must be stressed that sampling was not quantitatively precise.
In conclusion, a good quality sputum specimen can be obtained by sputum induction in the majority of children with CAP, and the microbiological yield of these induced sputum specimens is good. However, our observations do not support the routine use of induced sputum analysis for all children with CAP since the children found inhalation of hypertonic saline and repeated nasopharyngeal aspirations unpleasant. In addition, most children were successfully treated with empirical antibiotic therapy. In accordance with the IDSA and ATS guidelines for adults, we think that induced sputum analysis could be beneficial in children needing admission to the intensive care unit, in children with failure of first-line antibiotic therapy and in those with pleural effusion.6
The authors thank all the children who participated in this study, Kaisu Kaistinen, RN, for her excellent assistance in the conduct of this study, Tiina Haarala, Kirsi Sundholm-Heino and Tiina Ylinen for skilful technical assistance, Jaakko Matomäki for his assistance in statistical analysis and the staff members at the Paediatric Infectious Disease Ward for their collaboration in performing the sputum induction on study children.
Funding: The Foundation of the Finnish Anti-Tuberculosis Association, The Finnish Foundation for Paediatric Research, The Maud Kuistila Foundation, The Paulo Foundation, and The Turku University Foundation.
Competing interests: None.
Ethics approval: The study was approved by the ethics committee of the Hospital District of South-West Finland. Signed informed consent was obtained from the parent or guardian before enrolment.